Table 2.
Overall versus PLD outcomes
| Outcome | Ns | Overall | PLD | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N p | PE (%) | 95% CI | I2 (%) | N s | N p | PE (%) | 95% CI | I2 (%) | ||
| Recurrence | 62 | 1314 | 9.6 | 6.9–12.8 | 68 | 15 | 146 | 33.7* | 18.7–50.4 | 76 |
| Reintervention | 56 | 1176 | 7.1 | 5.0–9.4 | 50 | 10 | 109 | 26.4* | 12.6–43.0 | 69 |
| Complications | 60 | 1276 | 10.8 | 8.1–13.9 | 62 | 13 | 129 | 29.3* | 16.0–44.5 | 69 |
| Major | 56 | 1106 | 3.3 | 2.2–4.7 | 27 | 13 | 129 | 7.2 | 2.1–14.6 | 46 |
| Conversions | 44 | 889 | 4.5 | 3.2–6.0 | 0 | 9 | 83 | 8.2 | 3.2–15.0 | 0 |
| Mortality | 60 | 1271 | 1.0 | 0.5–1.6 | 0 | 13 | 135 | 2.3 | 0.4–5.6 | 0 |
Asterisk (*): statistically significant difference
PLD polycystic liver disease, Ns number of studies, Np number of patients, PE pooled estimate, CI confidence interval